MedPath

G.ST Antivirals GmbH

G.ST Antivirals GmbH logo
🇦🇹Austria
Ownership
Holding
Established
2019-10-01
Employees
11
Market Cap
-
Website
https://www.gst-antivirals.com

A Controlled Human Rhinovirus Infection Study of 2-Deoxy-D-Glucose in Healthy Adults

Phase 2
Terminated
Conditions
Acute Nasopharyngitis
Interventions
First Posted Date
2024-04-19
Last Posted Date
2024-11-19
Lead Sponsor
G.ST Antivirals GmbH
Target Recruit Count
64
Registration Number
NCT06375772
Locations
🇳🇱

Centre for Human Drug Research, Leiden, Netherlands

Safety and Pharmacokinetic Study of Intranasal 2-DG in Healthy Volunteers

Phase 1
Completed
Conditions
Acute Nasopharyngitis
Interventions
Other: Placebo
First Posted Date
2022-04-07
Last Posted Date
2023-10-12
Lead Sponsor
G.ST Antivirals GmbH
Target Recruit Count
45
Registration Number
NCT05314933
Locations
🇦🇹

Medical University of Vienna, Vienna, Austria

© Copyright 2025. All Rights Reserved by MedPath